MEKTOVI
Drug timelines are a Plus or Pro feature.
23 regulatory and trial events tracked for MEKTOVI, covering 2018-06-27 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer [Phase 2]